Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 697

1.

Second primary cancers in long-term survivors of glioblastoma.

Kim JY, Jackman JG, Woodring S, McSherry F, Herndon JE, Desjardins A, Friedman HS, Peters KB.

Neurooncol Pract. 2019 Sep;6(5):386-391. doi: 10.1093/nop/npz001. Epub 2019 Feb 4.

PMID:
31555453
2.

Risk assessment of post-discharge mortality among recently hospitalized Medicare heart failure patients with reduced or preserved ejection fraction.

Stampehl M, Friedman HS, Navaratnam P, Russo P, Park S, Obi EN.

Curr Med Res Opin. 2019 Sep 13:1-10. doi: 10.1080/03007995.2019.1662654. [Epub ahead of print]

PMID:
31469001
3.

Randomized open-label phase II trial of 5-day aprepitant plus ondansetron compared to ondansetron alone in the prevention of chemotherapy-induced nausea-vomiting (CINV) in glioma patients receiving adjuvant temozolomide.

Patel MP, Woodring S, Randazzo DM, Friedman HS, Desjardins A, Healy P, Herndon JE 2nd, McSherry F, Lipp ES, Miller E, Peters KB, Affronti ML.

Support Care Cancer. 2019 Aug 22. doi: 10.1007/s00520-019-05039-x. [Epub ahead of print]

PMID:
31440823
4.

Comparative effectiveness of budesonide inhalation suspension and montelukast in children with mild asthma in Korea.

Shin J, Oh SJ, Petigara T, Tunceli K, Urdaneta E, Navaratnam P, Friedman HS, Park SW, Hong SH.

J Asthma. 2019 Aug 6:1-11. doi: 10.1080/02770903.2019.1648504. [Epub ahead of print]

PMID:
31386600
5.

Complementary and integrative health interventions and their association with health-related quality of life in the primary brain tumor population.

Randazzo DM, McSherry F, Herndon JE, Affronti ML, Lipp ES, Flahiff C, Miller E, Woodring S, Boulton S, Desjardins A, Ashley DM, Friedman HS, Peters KB.

Complement Ther Clin Pract. 2019 Aug;36:43-48. doi: 10.1016/j.ctcp.2019.05.002. Epub 2019 May 18.

PMID:
31383442
6.

A Health System-Based Investment Case for Adolescent Health.

Sweeny K, Friedman HS, Sheehan P, Fridman M, Shi H.

J Adolesc Health. 2019 Jul;65(1S):S8-S15. doi: 10.1016/j.jadohealth.2019.03.023.

PMID:
31228990
7.

An Investment Case to Guarantee the Rights of Adolescents.

Chalasani S, Engel D, Friedman HS, Knutsson A, Mahon J, Patton G, Sawyer SM.

J Adolesc Health. 2019 Jul;65(1S):S3-S7. doi: 10.1016/j.jadohealth.2019.04.015. No abstract available.

PMID:
31228987
8.

Evaluating the Employment Benefits of Education and Targeted Interventions to Reduce Child Marriage.

Rasmussen B, Maharaj N, Sheehan P, Friedman HS.

J Adolesc Health. 2019 Jul;65(1S):S16-S24. doi: 10.1016/j.jadohealth.2019.03.022.

PMID:
31228985
9.

Single-institution retrospective review of patients with recurrent glioblastoma treated with bevacizumab in clinical practice.

Desjardins A, Herndon JE 2nd, McSherry F, Ravelo A, Lipp ES, Healy P, Peters KB, Sampson JH, Randazzo D, Sommer N, Friedman AH, Friedman HS.

Health Sci Rep. 2019 Feb 13;2(4):e114. doi: 10.1002/hsr2.114. eCollection 2019 Apr.

10.

MTAP Loss Promotes Stemness in Glioblastoma and Confers Unique Susceptibility to Purine Starvation.

Hansen LJ, Sun R, Yang R, Singh SX, Chen LH, Pirozzi CJ, Moure CJ, Hemphill C, Carpenter AB, Healy P, Ruger RC, Chen CJ, Greer PK, Zhao F, Spasojevic I, Grenier C, Huang Z, Murphy SK, McLendon RE, Friedman HS, Friedman AH, Herndon JE 2nd, Sampson JH, Keir ST, Bigner DD, Yan H, He Y.

Cancer Res. 2019 Jul 1;79(13):3383-3394. doi: 10.1158/0008-5472.CAN-18-1010. Epub 2019 Apr 30.

PMID:
31040154
11.

A Systematic Global Review of Condom Availability Programs in High Schools.

Algur E, Wang E, Friedman HS, Deperthes B.

J Adolesc Health. 2019 Mar;64(3):292-304. doi: 10.1016/j.jadohealth.2018.11.013. Review.

PMID:
30819331
12.

Trends in Asthma Control, Treatment, Health Care Utilization, and Expenditures Among Children in the United States by Place of Residence: 2003-2014.

Sullivan PW, Ghushchyan V, Kavati A, Navaratnam P, Friedman HS, Ortiz B.

J Allergy Clin Immunol Pract. 2019 Jul - Aug;7(6):1835-1842.e2. doi: 10.1016/j.jaip.2019.01.055. Epub 2019 Feb 15.

PMID:
30772478
13.

Exploring factors associated with health disparities in asthma and poorly controlled asthma among school-aged children in the U.S.

Sullivan PW, Ghushchyan V, Navaratnam P, Friedman HS, Kavati A, Ortiz B, Lanier B.

J Asthma. 2019 Feb 7:1-14. doi: 10.1080/02770903.2019.1571080. [Epub ahead of print]

PMID:
30732486
14.

Neuroticism and health as individuals age.

Friedman HS.

Personal Disord. 2019 Jan;10(1):25-32. doi: 10.1037/per0000274. Review.

15.

MGMT: Immunohistochemical Detection in High-Grade Astrocytomas.

Lipp ES, Healy P, Austin A, Clark A, Dalton T, Perkinson K, Herndon JE, Friedman HS, Friedman AH, Bigner DD, McLendon RE.

J Neuropathol Exp Neurol. 2019 Jan 1;78(1):57-64. doi: 10.1093/jnen/nly110.

PMID:
30500933
16.

Understanding drivers of domestic public expenditure on reproductive, maternal, neonatal and child health in Peru at district level: an ecological study.

Huicho L, Hernandez P, Huayanay-Espinoza CA, Segura ER, Ni├▒o de Guzman J, Flores-Cordova G, Rivera-Ch M, Friedman HS, Berman P.

BMC Health Serv Res. 2018 Nov 6;18(1):833. doi: 10.1186/s12913-018-3649-x.

17.

Adjunctive perampanel for glioma-associated epilepsy.

Dunn-Pirio AM, Woodring S, Lipp E, Herndon JE 2nd, Healy P, Weant M, Randazzo D, Desjardins A, Friedman HS, Peters KB.

Epilepsy Behav Case Rep. 2018 Oct 9;10:114-117. doi: 10.1016/j.ebcr.2018.09.003. eCollection 2018.

18.

Cultivating healthy trajectories: An experimental study of community gardening and health.

Heilmayr D, Friedman HS.

J Health Psychol. 2018 Sep 21:1359105318800784. doi: 10.1177/1359105318800784. [Epub ahead of print]

PMID:
30238812
19.

Recurrent Glioblastoma Treated with Recombinant Poliovirus.

Desjardins A, Gromeier M, Herndon JE 2nd, Beaubier N, Bolognesi DP, Friedman AH, Friedman HS, McSherry F, Muscat AM, Nair S, Peters KB, Randazzo D, Sampson JH, Vlahovic G, Harrison WT, McLendon RE, Ashley D, Bigner DD.

N Engl J Med. 2018 Jul 12;379(2):150-161. doi: 10.1056/NEJMoa1716435. Epub 2018 Jun 26.

20.

The genomic landscape of TERT promoter wildtype-IDH wildtype glioblastoma.

Diplas BH, He X, Brosnan-Cashman JA, Liu H, Chen LH, Wang Z, Moure CJ, Killela PJ, Loriaux DB, Lipp ES, Greer PK, Yang R, Rizzo AJ, Rodriguez FJ, Friedman AH, Friedman HS, Wang S, He Y, McLendon RE, Bigner DD, Jiao Y, Waitkus MS, Meeker AK, Yan H.

Nat Commun. 2018 May 25;9(1):2087. doi: 10.1038/s41467-018-04448-6.

21.

Health Disparities Among Children with Asthma in the United States by Place of Residence.

Sullivan PW, Ghushchyan V, Kavati A, Navaratnam P, Friedman HS, Ortiz B.

J Allergy Clin Immunol Pract. 2019 Jan;7(1):148-155. doi: 10.1016/j.jaip.2018.05.001. Epub 2018 May 18.

PMID:
29782937
22.

Phase II Study to Evaluate the Efficacy and Safety of Rilotumumab and Bevacizumab in Subjects with Recurrent Malignant Glioma.

Affronti ML, Jackman JG, McSherry F, Herndon JE 2nd, Massey EC Jr, Lipp E, Desjardins A, Friedman HS, Vlahovic G, Vredenburgh J, Peters KB.

Oncologist. 2018 Aug;23(8):889-e98. doi: 10.1634/theoncologist.2018-0149. Epub 2018 Apr 17.

23.

Sym004-induced EGFR elimination is associated with profound anti-tumor activity in EGFRvIII patient-derived glioblastoma models.

Keir ST, Chandramohan V, Hemphill CD, Grandal MM, Melander MC, Pedersen MW, Horak ID, Kragh M, Desjardins A, Friedman HS, Bigner DD.

J Neurooncol. 2018 Jul;138(3):489-498. doi: 10.1007/s11060-018-2832-6. Epub 2018 Mar 21.

24.

Phase I/II trial of vorinostat, bevacizumab, and daily temozolomide for recurrent malignant gliomas.

Peters KB, Lipp ES, Miller E, Herndon JE 2nd, McSherry F, Desjardins A, Reardon DA, Friedman HS.

J Neurooncol. 2018 Apr;137(2):349-356. doi: 10.1007/s11060-017-2724-1. Epub 2017 Dec 21.

PMID:
29264836
25.

Phase II Study of Bevacizumab and Vorinostat for Patients with Recurrent World Health Organization Grade 4 Malignant Glioma.

Ghiaseddin A, Reardon D, Massey W, Mannerino A, Lipp ES, Herndon JE 2nd, McSherry F, Desjardins A, Randazzo D, Friedman HS, Peters KB.

Oncologist. 2018 Feb;23(2):157-e21. doi: 10.1634/theoncologist.2017-0501. Epub 2017 Nov 13.

26.

Adaptive Evolution of the GDH2 Allosteric Domain Promotes Gliomagenesis by Resolving IDH1R132H-Induced Metabolic Liabilities.

Waitkus MS, Pirozzi CJ, Moure CJ, Diplas BH, Hansen LJ, Carpenter AB, Yang R, Wang Z, Ingram BO, Karoly ED, Mohney RP, Spasojevic I, McLendon RE, Friedman HS, He Y, Bigner DD, Yan H.

Cancer Res. 2018 Jan 1;78(1):36-50. doi: 10.1158/0008-5472.CAN-17-1352. Epub 2017 Nov 2.

27.

Dendritic Cells Enhance Polyfunctionality of Adoptively Transferred T Cells That Target Cytomegalovirus in Glioblastoma.

Reap EA, Suryadevara CM, Batich KA, Sanchez-Perez L, Archer GE, Schmittling RJ, Norberg PK, Herndon JE 2nd, Healy P, Congdon KL, Gedeon PC, Campbell OC, Swartz AM, Riccione KA, Yi JS, Hossain-Ibrahim MK, Saraswathula A, Nair SK, Dunn-Pirio AM, Broome TM, Weinhold KJ, Desjardins A, Vlahovic G, McLendon RE, Friedman AH, Friedman HS, Bigner DD, Fecci PE, Mitchell DA, Sampson JH.

Cancer Res. 2018 Jan 1;78(1):256-264. doi: 10.1158/0008-5472.CAN-17-0469. Epub 2017 Nov 1.

28.

The national burden of poorly controlled asthma, school absence and parental work loss among school-aged children in the United States.

Sullivan PW, Ghushchyan V, Navaratnam P, Friedman HS, Kavati A, Ortiz B, Lanier B.

J Asthma. 2018 Jun;55(6):659-667. doi: 10.1080/02770903.2017.1350972. Epub 2017 Oct 5.

PMID:
28981368
29.

The national cost of asthma among school-aged children in the United States.

Sullivan PW, Ghushchyan V, Navaratnam P, Friedman HS, Kavati A, Ortiz B, Lanier B.

Ann Allergy Asthma Immunol. 2017 Sep;119(3):246-252.e1. doi: 10.1016/j.anai.2017.07.002.

PMID:
28890020
30.

Scaling up family planning in Sierra Leone: A prospective cost-benefit analysis.

Keen S, Begum H, Friedman HS, James CD.

Womens Health (Lond). 2017 Dec;13(3):43-57. doi: 10.1177/1745505717724617. Epub 2017 Aug 29.

PMID:
28849728
31.

National Prevalence of Poor Asthma Control and Associated Outcomes Among School-Aged Children in the United States.

Sullivan PW, Ghushchyan V, Navaratnam P, Friedman HS, Kavati A, Ortiz B, Lanier B.

J Allergy Clin Immunol Pract. 2018 Mar - Apr;6(2):536-544.e1. doi: 10.1016/j.jaip.2017.06.039. Epub 2017 Aug 26.

PMID:
28847656
32.

Animation Stimuli System for Research on Instructor Gestures in Education.

Cui J, Popescu V, Adamo-Villani N, Wagner Cook S, Duggan KA, Friedman HS.

IEEE Comput Graph Appl. 2017;37(4):72-83. doi: 10.1109/MCG.2017.3271471.

PMID:
28829295
33.

Indicators of poorly controlled asthma and health-related quality of life among school-age children in the United States.

Sullivan PW, Ghushchyan V, Navaratnam P, Friedman HS, Kavati A, Ortiz B, Lanier B.

Allergy Asthma Proc. 2017 Nov 11;38(6):431-439. doi: 10.2500/aap.2017.38.4084. Epub 2017 Aug 11.

PMID:
28800789
34.

A cross sectional analysis from a single institution's experience of psychosocial distress and health-related quality of life in the primary brain tumor population.

Randazzo DM, McSherry F, Herndon JE 2nd, Affronti ML, Lipp ES, Flahiff C, Miller E, Woodring S, Freeman M, Healy P, Minchew J, Boulton S, Desjardins A, Vlahovic G, Friedman HS, Keir S, Peters KB.

J Neurooncol. 2017 Sep;134(2):363-369. doi: 10.1007/s11060-017-2535-4. Epub 2017 Jul 1.

PMID:
28669010
35.

Assessment of treatment patterns associated with injectable disease-modifying therapy among relapsing-remitting multiple sclerosis patients.

Nicholas J, Ko JJ, Park Y, Navaratnam P, Friedman HS, Ernst FR, Herrera V.

Mult Scler J Exp Transl Clin. 2017 Mar 17;3(1):2055217317696114. doi: 10.1177/2055217317696114. eCollection 2017 Jan-Mar.

36.

The case for investing in the male condom.

Stover J, Rosen JE, Carvalho MN, Korenromp EL, Friedman HS, Cogan M, Deperthes B.

PLoS One. 2017 May 16;12(5):e0177108. doi: 10.1371/journal.pone.0177108. eCollection 2017.

37.

School absence and productivity outcomes associated with childhood asthma in the USA.

Sullivan P, Ghushchyan VG, Navaratnam P, Friedman HS, Kavati A, Ortiz B, Lanier B.

J Asthma. 2018 Feb;55(2):161-168. doi: 10.1080/02770903.2017.1313273. Epub 2017 Apr 28.

PMID:
28453370
38.

Building the foundations for sustainable development: a case for global investment in the capabilities of adolescents.

Sheehan P, Sweeny K, Rasmussen B, Wils A, Friedman HS, Mahon J, Patton GC, Sawyer SM, Howard E, Symons J, Stenberg K, Chalasani S, Maharaj N, Reavley N, Shi H, Fridman M, Welsh A, Nsofor E, Laski L.

Lancet. 2017 Oct 14;390(10104):1792-1806. doi: 10.1016/S0140-6736(17)30872-3. Epub 2017 Apr 19.

PMID:
28433259
39.

Long-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination.

Batich KA, Reap EA, Archer GE, Sanchez-Perez L, Nair SK, Schmittling RJ, Norberg P, Xie W, Herndon JE 2nd, Healy P, McLendon RE, Friedman AH, Friedman HS, Bigner D, Vlahovic G, Mitchell DA, Sampson JH.

Clin Cancer Res. 2017 Apr 15;23(8):1898-1909. doi: 10.1158/1078-0432.CCR-16-2057.

40.

A Phase II single-arm trial of palonosetron for the prevention of acute and delayed chemotherapy-induced nausea and vomiting in malignant glioma patients receiving multidose irinotecan in combination with bevacizumab.

Affronti ML, Woodring S, Peters KB, Herndon JE 2nd, McSherry F, Healy PN, Desjardins A, Vredenburgh JJ, Friedman HS.

Ther Clin Risk Manag. 2016 Dec 23;13:33-40. doi: 10.2147/TCRM.S122480. eCollection 2017.

41.

A Phase II feasibility study of oral etoposide given concurrently with radiotherapy followed by dose intensive adjuvant chemotherapy for children with newly diagnosed high-risk medulloblastoma (protocol POG 9631): A report from the Children's Oncology Group.

Esbenshade AJ, Kocak M, Hershon L, Rousseau P, Decarie JC, Shaw S, Burger P, Friedman HS, Gajjar A, Moghrabi A.

Pediatr Blood Cancer. 2017 Jun;64(6). doi: 10.1002/pbc.26373. Epub 2016 Dec 21.

43.

Association between cardiac, renal, and hepatic biomarkers and outcomes in patients with acute heart failure.

Chan WW, Waltman Johnson K, Friedman HS, Navaratnam P.

Hosp Pract (1995). 2016 Aug;44(3):138-45. doi: 10.1080/21548331.2016.1197760. Epub 2016 Jun 15.

PMID:
27292609
44.

Phase II study to evaluate the safety and efficacy of intravenous palonosetron (PAL) in primary malignant glioma (MG) patients receiving standard radiotherapy (RT) and concomitant temozolomide (TMZ).

Affronti ML, Woodring S, Allen K, Kirkpatrick J, Peters KB, Herndon JE 2nd, McSherry F, Healy PN, Desjardins A, Vredenburgh JJ, Friedman HS.

Support Care Cancer. 2016 Oct;24(10):4365-75. doi: 10.1007/s00520-016-3276-1. Epub 2016 Jun 6.

PMID:
27271867
45.

Comparative Assessment of Medical Resource Use and Costs Associated with Patients with Symptomatic Peripheral Artery Disease in the United States.

Chase MR, Friedman HS, Navaratnam P, Heithoff K, Simpson RJ Jr.

J Manag Care Spec Pharm. 2016 Jun;22(6):667-75. doi: 10.18553/jmcp.2016.15010. Epub 2016 Apr 28.

46.

Determinants of high cost in multiple sclerosis patients: a claims and chart review study.

Ke X, Navaratnam P, Sasane R, Eisenberg Lawrence DF, Friedman HS, Tulsi BB, Vollmer T.

Curr Med Res Opin. 2016 Sep;32(9):1589-97. doi: 10.1080/03007995.2016.1192529. Epub 2016 Jun 25.

PMID:
27207562
47.

Hand Gesture and Mathematics Learning: Lessons From an Avatar.

Cook SW, Friedman HS, Duggan KA, Cui J, Popescu V.

Cogn Sci. 2017 Mar;41(2):518-535. doi: 10.1111/cogs.12344. Epub 2016 Apr 29.

48.

Vaccine Therapy, Oncolytic Viruses, and Gliomas.

Desjardins A, Vlahovic G, Friedman HS.

Oncology (Williston Park). 2016 Mar;30(3):211-8. Review.

49.

Gender Disparities in Lipid-Lowering Therapy in Cardiovascular Disease: Insights from a Managed Care Population.

Rodriguez F, Olufade TO, Ramey DR, Friedman HS, Navaratnam P, Heithoff K, Foody JM.

J Womens Health (Larchmt). 2016 Jul;25(7):697-706. doi: 10.1089/jwh.2015.5282. Epub 2016 Feb 18.

PMID:
26889924
50.

Resource use and costs in high-risk symptomatic peripheral artery disease patients with diabetes and prior acute coronary syndrome: a retrospective analysis.

Reed Chase M, Friedman HS, Navaratnam P, Heithoff K, Simpson RJ Jr.

Postgrad Med. 2016;128(2):170-9. doi: 10.1080/00325481.2016.1144447. Epub 2016 Feb 17.

PMID:
26788980

Supplemental Content

Loading ...
Support Center